Since its launch in 2014, the Child Dental Benefits Schedule has seen a gradual increase in participation year on year. The impact of COVID-19 and related shutdowns saw participation fall sharply in 2020. Though it increased 2021, the national target of 41% participation was not reached in 2021-2022, with the total (35.4%) more than three percent below 2018 participation rates.
Strong participation rates in programs like the CDBS cannot be understated. Good oral health habits, preventative treatment and regular check ups all play a major role in good oral health as people enter adulthood. Current statistics show issues with oral health in early life have a major impact on both the individual and a flow on effect on the national health system. Reducing the rates of potentially preventable hospitalisations due to dental conditions is one of the Key Performance Indicators of the National Oral Health Plan 2015–2024
Australian Dental Industry Association (ADIA) has sourced the following data on Oral Health, hospitalisations, and children in Australia
In 2019–20, about 67,000 hospitalisations for dental conditions may have been prevented with earlier treatment.
- In 2019-20, 5–9-year old’s had the highest rate of potentially preventable hospitalisations.
- 22,900 children aged 0-9 were hospitalised for dental conditions that may have been prevented with earlier treatment.
- Around twice as many people eligible for public dental care (39%) stated they would have difficulty paying for a basic preventive visit than those ineligible for public dental care (18%).
- People who usually visit the dentist for a problem (58%) were more than twice as likely as those who usually visit for a check-up (27%) to avoid or delay visiting a dentist due to cost.
As the peak industry body representing suppliers, manufacturers, and wholesalers to Australian oral health professionals, Australian Dental Industry Association (ADIA), sees opportunity to make a measurable difference to the health of children in Australia. ADIA believes increased awareness of the Child Dental Benefits Schedule will increase preventative care, create better habits, and improve health outcomes for Australian children. Reducing preventable hospitalisations in children under 18 will have the added benefit of easing public health system congestion resulting an improved functioning national healthcare system overall.
In an opinion segment, Australian Health Journal spoke with Abano Healthcare Group Clinical Director, Dr Fred Calavassy, with over 30 years of clinical experience, about his observations of the Child Dental Benefits Scheme ways to increasing participation rates.
-
Pharmacist Prescribing Model gets further support from state health
A full scope pharmacist prescriber model allows pharmacists to independently prescribe medicines within their professional competence, without requiring prior doctor authorisation. It extends pharmacists’ role beyond dispensing to include assessment, diagnosis of minor and chronic conditions, initiation and modification of therapy, and ongoing patient monitoring. This model integrates pharmacists into primary care teams, aiming to improve timely access to treatment, reduce pressure on general practitioners, and enhance continuity of care. Pharmacists use their clinical knowledge, patient records, and collaborative pathways to ensure safe prescribing. The model emphasises training, regulation, and accountability to maintain high standards of patient safety.
-
Investments to address health inequities in Prostate Cancer Care
Income, education, geographical location, and discrimination based on ethnicity, race, gender and sexual orientation, are only a fraction of factors that can negatively affect a person’s quality of cancer care. This is defined as the “equity gap” and it’s costing people their lives.
Timed to coincide with World Cancer Day 4th February 2025, Movember announced prostate cancer investment of $5.5 million. Eighteen grants (16 proposals and 2 community development grants) are slated to directly tackle inequities in prostate cancer care. The funding will be over three years with the grants spread across five countries – six in Canada, five in the United Kingdom, three in Australia, three in the United States and one in Ireland – each having a specific focus population and care area.
-
Observations in diagnosis and treatment of oral cancer over the past 45 years
Peter Thomson is Academic Head of Dentistry and Professor of Oral & Maxillofacial Sciences in the College of Medicine & Dentistry at James Cook University, Australia. A UK and Australian specialist in Oral & Maxillofacial Surgery and Oral Medicine, he qualified BDS from Manchester University and MBBS from Newcastle upon Tyne, gaining Fellowships in Dental Surgery from the Royal College of Surgeons of England, Ireland and Glasgow and a Fellowship in Surgery from Edinburgh, specializing in Head & Neck Oncology.
